ion-pairing reagent heptafluorobutyric acid produced baseline separation of angiotensin peptides. Ang II was collected as a single fraction, concentrated by evaporation to dryness, and measured by RIA after resuspension in RIA buffer. Even including column washing between sample injections to prevent carryover of plasma constituents, two plasma extracts could be processed RIA (9, 11, 13-18) .
the entire angiotensin pool, not just Ang II. To circumvent this problem, several investigators have used HPLC to separate Ang TI-related peptides before measurement of Ang II by RIA (9, 11, 13-18).
Reversed-phase HPLC systems involving either isocratic or gradient elution have been used in conjunction with RIA to quantify specific angiotensins (9, 11, 13-18). These assays are limited in several important respects. For example, isocratic elution procedures frequently contain nonvolatile components in the mobile phase (9, 13). Multiple small-volume fractions are collected and assayed, and their amounts summed (9, 11, 13)-a practice that requires a large number of RIAs to be performed, introduces error due to multiple determinations, and compromises sensitivity.
In addition, plasma constituents accumulate with successive injections and shorten the effective life span of the column (9, 13). Gradient systems have been encumbered by high column temperatures, a requirement of intermittent column cleansing, or a long retention time for Ang II (14-18).
We have used the ion-pairing reagent heptafluorobutyiic acid (HFBA) to develop an HPLC system that avoids all of the shortcomings.
The angiotensuns are resolved completely by isocratic elution at 38#{176}C. Ang IT elutes in <12 mm in a volume of <0.8 mL. The chromatographic system can be cleaned and reequilibrated quicidy enough to permit processing of two samples per hour. Because the mobile-phase components are volatile, RIA quantification of Ang II can be done with a single fraction of eluate after evaporation and resuspension in assay buffer. This reduces the number of RIAs performed to one per sample, thereby improving the precision of measurement for each sample. Results for plasma sampies from humans under basal and stimulated conditions confirmed the clinical utility of the assay. 
Materialsand Methods

Chemicals and Reagents
Results
Sensitivity and Specificity of AlA Figure 1 depicts mean Ang II calibration curve data (± SD) from eight RIAs. About 1.0 pg of Ang II produced a statistically significant displacement of tracer. As indicated in Fig. 2 , the rabbit antiserum to Ang II was not specific for the Ang II octapeptide, but substantially cross-reacted with related peptides containing a C-terminal phenylalanine.
Other angiotensin peptides, including Ang I, displayed <1% cross-reactivity (data not shown). To mRzimize specificity for Ang II, we developed a HPLC procedure specifically optimized for resolving Ang II and the three related peptides that cross-reacted with antibody.
We used SPE followed by HPLC to isolate authentic Ang II before analysis by RIA. In agreement with other reports (9, 11), we obtained a high recovery (89%) for Ang H through the SPE procedure. Fig. 3 
Precision,Accuracy,and Recovery
The intra-and interassay precision were determined by processing four 2-xnL plasma samples from a common pool on four separate days. The intraassay CVs were 3.6%, 5.9%, 6.2%, and 8.3%, respectively, with an overall interassay CV of 10.3%. Duplicate 2.0-mL samples of RIA buffer with added Ang II to yield a final concentration of 5.0, 10.0, or 20.0 ngIL were processed through the entire assay to assess recovery (shown in Table 1 ). Precision and recovery were also estimated by supplementing pooled plasma with Ang IT to increase the concentration by lOng/Land analyzing 2.0-niL samples of both the supplemented and unsupplemented plasma ( Table   2 ). The overall recovery of Ang II was 75%, calculated by dividing the difference between the means of the two pools by 20 pg. (14) (15) (16) (17) (18) . Some limita-
Studies in Healthy Volunteers
The individual results of plasma Ang TIconcentration obtained from four healthy young adults are shown in Fig. 4 . Ingestion of furosemide along with assumption of an upright posture produced an average 3.9-fold increase in the plasma concentration of Ang II; however, this difference was not statistically significant (P = 0.068). Table 3 and Fig. 5 show data for the reninangiotensin-aldosterone system in healthy young subjects and elderly individuals, all on diets of 30 and 150 mmollday sodium. Compared with the younger group, the elderly had significantly lower plasma Ang II concentrations on both diets. The disparities between age groups occurred despite identical diets with comparable amounts of 24-h urine sodium excretion (Table 3) . Although no significant difference was found for PAC on 
Supln.
Fureasmid. UVNa, urinesodium excretion. (9, 13) ; to circumvent this problem, the investigators collected multiple small postcolumn fractions and assayed them directly, estimating the total amount of peptide as the sum of the individual fractions. This practice requires performing a large number of RlAs, increases the error in quantification, and decreases the sensitivity of the entire assay. In contrast, our isocratic elution conditions produced sharp peaks and excellent separation between endogenous angiotensin peptides (Fig. 3) (25) (26) (27) .
In 10 validation assays, the mean nonspecific binding was 1.5% ± 0.6% for a maximum binding of 35.1% ± 2.1%. The slope and the concentration of Ang II necessary to produce 50% displacement of tracer were 0.97 ± 0.05 and 11.7 ± 1.6 ngIL, respectively, with CVs for all calibration curve parameters being <12.5%. For 2 mL of plasma, the detection limit (sensitivity) of the RIA was 1.3 ngIL. Thus, we conclude that PEGassisted second-antibody precipitation is well suited as a separation method for use in RIAs of Ang II.
To examine the clinical utility of the assay, we measured human plasma Ang H concentrations under basal and stimulated conditions. Several factors affect RAS activity, including dietary sodium intake (28), posture (9), furosemide administration (9), and age (29-31). We found basal Ang H concentration in subjects on an ad libitum diet to be comparable with that measured by others (9, 11, 13-18). When subjects were given a low dose of furosemide and assumed an upright posture to stimulate production of Ang II, plasma concentrations of Ang II increased severalfold (Fig. 4) . We also measured PRA, PAC, and plasma Ang II concentrations in three young and three elderly subjects on low-and normalsodium diets. Although PRA and PAC are known to decline with age (29) (30) (31) , data on the effects of age on plasma Ang II concentration are contradictory, with reports indicating that the elderly have normal (32-34) and low (35, 36) plasma Ang II concentrations.
However, those results were not based on measuring authentic Ang II concentration.
In our subjects, who were in virtually identical states of sodium balance (Table 3) , we found that, on both diets, the concentration of Ang TI was less in the elderly than in their younger counterparts (Fig. 5) . A restricted sodium diet stimulated Ang II in both age groups; however, the magnitude of increase was blunted in the elderly. These results support the finding that circulating RAS activity is reduced in senescence (29) (30) (31) .
In conclusion, we developed a HPLC method with isocratic elution that, in conjunction with SPE and RIA, demonstrates high precision and recovery of authentic Ang II under physiological conditions. The method permits a reasonable rate of sample processing and minimizes the number of RIAs that must be performed to quantify authentic Ang II in physiological fluids.
